Lipid profiling reveals arachidonate deficiency in RAW264.7 cells: Structural and functional implications

被引:69
作者
Rouzer, Carol A.
Ivanova, Pavlina T.
Byrne, Mark O.
Milne, Stephen B.
Marnett, Lawrence J.
Brown, H. Alex
机构
[1] Vanderbilt Univ, Sch Med,Ctr Pharmacol & Drug Toxicol, Dept Pharmacol,Ctr Mol Toxicol, Vanderbilt Inst Chem Biol,Vanderbilt Ingram Canc, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med,Ctr Pharmacol & Drug Toxicol, Dept Biochem,Ctr Mol Toxicol, Vanderbilt Inst Chem Biol,Vanderbilt Ingram Canc, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med,Ctr Pharmacol & Drug Toxicol, Dept Chem,Ctr Mol Toxicol, Vanderbilt Inst Chem Biol,Vanderbilt Ingram Canc, Nashville, TN 37232 USA
关键词
D O I
10.1021/bi061723j
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glycerophospholipids containing arachidonic acid (20:4) serve as the precursors for an array of biologically active lipid mediators, most of which are produced by macrophages. We have applied mass spectrometry-based lipid profiling technology to evaluate the glycerophospholipid structure and composition of two macrophage populations, resident peritoneal macrophages and RAW264.7 cells, with regard to their potential for 20:4-based lipid mediator biosynthesis. Fatty acid analysis indicated that RAW264.7 cells were deficient in 20:4 (10 +/- 1 mol %) compared to peritoneal macrophages (26 +/- 1 mol %). Mass spectrometry of total glycerophospholipids demonstrated a marked difference in the distribution of lipid species, including reduced levels of 20: 4-containing lipids, in RAW264.7 cells compared to peritoneal macrophages. Enrichment of RAW264.7 cells with 20:4 increased the fatty acid to 20 +/- 1 mol %. However, the distribution of the incorporated 20:4 remained different from that of peritoneal macrophages. RAW264.7 cells pretreated with granulocyte-macrophage colony stimulating factor followed by lipopolysaccharide and interferon-gamma mobilized similar quantities of 20:4 and produced similar amounts of prostaglandins as peritoneal macrophages treated with LPS alone. LPS treatment resulted in detectable changes in specific 20:4-containing glycerophospholipids in peritoneal cells, but not in RAW264.7 cells. 20:4-enriched RAW264.7 cells lost 88% of the incorporated fatty acid during the LPS incubation without additional prostaglandin synthesis. These results illustrate that large differences in glycerophospholipid composition may exist, even in closely related cell populations, and demonstrate the importance of interpreting the potential for lipid-mediator biosynthesis in the context of overall glycerophospholipid composition.
引用
收藏
页码:14795 / 14808
页数:14
相关论文
共 45 条
[21]   GM-CSF priming of human monocytes is dependent on ERK1/2 activation [J].
Lendemans, S ;
Rani, M ;
Selbach, C ;
Kreuzfelder, E ;
Schade, FU ;
Flohé, S .
JOURNAL OF ENDOTOXIN RESEARCH, 2006, 12 (01) :10-20
[22]   Regulation of macrophage eicosanoid generation is dependent on nuclear factor κB [J].
Lo, CJ ;
Cryer, HG ;
Fu, MJ ;
Lo, FR .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1998, 45 (01) :19-23
[23]   RESPONSE OF ENDOCYTOSIS TO ALTERED FATTY ACYL COMPOSITION OF MACROPHAGE PHOSPHOLIPIDS [J].
MAHONEY, EM ;
HAMILL, AL ;
SCOTT, WA ;
COHN, ZA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (11) :4895-4899
[24]  
MAHONEY EM, 1980, J BIOL CHEM, V255, P4910
[25]   LIPIDS OF ALVEOLAR MACROPHAGES, POLYMORPHONUCLEAR LEUKOCYTES, AND THEIR PHAGOCYTIC VESICLES [J].
MASON, RJ ;
VAUGHAN, M ;
STOSSEL, TP .
JOURNAL OF CLINICAL INVESTIGATION, 1972, 51 (09) :2399-+
[26]  
MILNE SB, 2003, AFCS RES REPORT
[27]   Lipidomics: An analysis of cellular lipids by ESI-MS [J].
Milne, Stephen ;
Ivanova, Pavlina ;
Forrester, Jeffrey ;
Brown, H. Alex .
METHODS, 2006, 39 (02) :92-103
[28]  
Murphy R. C., 2002, MASS SPECTROMETRY PH
[29]  
NAKAGAWA Y, 1986, BIOCHIM BIOPHYS ACTA, V876, P601
[30]   Changes in arachidonic acid metabolism and the aggregation of polymorphonuclear leukocytes in rats with streptozotocin-induced diabetes [J].
Nakagawa, Y ;
Ishii, E .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1996, 1315 (02) :145-151